ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Continental AG (PK)

Continental AG (PK) (CTTAY)

6.81
0.20
(3.03%)
마감 06 12월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

CTTAY 뉴스

공식 뉴스 전용
band aid band aid 2 분 전
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 2 분 전
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 2 분 전
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 2 분 전
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 2 분 전
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 2 분 전
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 3 분 전
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ
Richard H2 Richard H2 4 분 전
Just in:

http://www.nashvillechanceryinfo.org/CaseDetail.aspx?CaseID=80738

IN THE CHANCERY COURT FOR THE STATE OF TENNESSEE
TWENTIETH JUDICIAL DISTRICT, DAVIDSON COUNTY – CASE No.23-1020-II

B&K ENERGY, LLC – Plaintiff
v
HOLCOMB ENE
BKH
Dr Quest Dr Quest 4 분 전
"Existing management has already for two years overstated the value of the Company by advancing the ~$10.00 per share NAV narrative. "

So with the current offer by Ready, the merger price comes in at 5.50+/share. That would be a erosion of value of 45% over two years. Over those same
MartinLutherKing MartinLutherKing 5 분 전
3.TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced initiation of its Pha
RNAZ
Gamco Gamco 6 분 전
style="font-size: 16px"From Gemini:
style="font-size: 16px"

style="font-size: 16px"The potential implications of Tesla's appeal for a UK global FRAND rate ruling against Avanci/InterDigital are significant and could reshape the landscape of patent licensing in the t
IDCC
Zorch305 Zorch305 6 분 전
Lots of goodluck with Multiple irons in the fire!!
RDAR
Dragonman1 Dragonman1 6 분 전
I never said I was looking at this Co For a pump and dump your a liar!
KEGS
northam43 northam43 6 분 전
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/5/kxaxx6_All_Cycles_Chart.png
MartinLutherKing MartinLutherKing 6 분 전
2. TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
May 29 2024 - 9:15AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer
RNAZ
No-Quarter No-Quarter 6 분 전
That's a new one for me. Added. Thx
PickStocks PickStocks 7 분 전
Quote: " style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"Chad and Doreen can’t tell you, I, or AZ anything."
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-fami
COOP
nowwhat2 nowwhat2 7 분 전
Oh no......Not again !

https://investorshub.advfn.com/uimage/uploads/2024/12/5/vxyosxrp_121212_5_hyper_CAPT_not_again.jpg



FOMO
XRPUSD
arizona1 arizona1 7 분 전
I absolutely can understand why the UHC president was murdered.

I don’t like that it happened, but I can understand why people would want him dead, given the reports of UHC denying coverage to patients, which in this day and age, can mean that those patients die for lack of treatment.
MartinLutherKing MartinLutherKing 8 분 전
1. TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cance
RNAZ
fwb fwb 10 분 전
NVDA will SUPPLY the HARDWARE (CHIPS)
The computers will be built by others.
PLTR will be one of the SOFTWARE Companies those Computers will run on that will help the companies using them to improve on efficiency
It's how all these companies will USE these products for their bus
NVDA PLTR
BeepBeepMF BeepBeepMF 10 분 전
that chart ❤️ what a beaut it is $RDAR
RDAR

최근 히스토리

Delayed Upgrade Clock